These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 21716161

  • 1. BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
    Gauchotte G, Philippe C, Lacomme S, Léotard B, Wissler MP, Allou L, Toussaint B, Klein M, Vignaud JM, Bressenot A.
    Pathology; 2011 Aug; 43(5):447-52. PubMed ID: 21716161
    [Abstract] [Full Text] [Related]

  • 2. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.
    Cancer; 2005 Jun 01; 103(11):2261-8. PubMed ID: 15880523
    [Abstract] [Full Text] [Related]

  • 3. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM, Huang YW, Huang JS, Wang CH, Kok VC, Hung CM, Chen HM, Tzen CY.
    Ann Surg Oncol; 2007 Oct 01; 14(10):3011-8. PubMed ID: 17638058
    [Abstract] [Full Text] [Related]

  • 4. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G.
    Clin Endocrinol (Oxf); 2008 Apr 01; 68(4):618-34. PubMed ID: 18070147
    [Abstract] [Full Text] [Related]

  • 5. Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis.
    Kim KH, Suh KS, Kang DW, Kang DY.
    Pathol Int; 2005 Sep 01; 55(9):540-5. PubMed ID: 16143028
    [Abstract] [Full Text] [Related]

  • 6. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma.
    Baitei EY, Zou M, Al-Mohanna F, Collison K, Alzahrani AS, Farid NR, Meyer B, Shi Y.
    J Pathol; 2009 Apr 01; 217(5):707-15. PubMed ID: 19156774
    [Abstract] [Full Text] [Related]

  • 7. [Expression of BRAF V600E mutation in different thyroid lesions].
    Wang W, Li XH, Zhang YH, Li J, Chen J, Zhao P, Li QY, Xiang JJ, Li X, Xu RJ.
    Zhonghua Zhong Liu Za Zhi; 2011 May 01; 33(5):354-7. PubMed ID: 21875464
    [Abstract] [Full Text] [Related]

  • 8. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, Monacelli M, Macchiarulo A, Santeusanio F, Tartaglia M, Puxeddu E.
    Clin Endocrinol (Oxf); 2006 Jan 01; 64(1):105-9. PubMed ID: 16402937
    [Abstract] [Full Text] [Related]

  • 9. BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas.
    Lee JH, Lee ES, Kim YS, Won NH, Chae YS.
    Pathology; 2006 Jun 01; 38(3):201-4. PubMed ID: 16753739
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.
    Koperek O, Kornauth C, Capper D, Berghoff AS, Asari R, Niederle B, von Deimling A, Birner P, Preusser M.
    Am J Surg Pathol; 2012 Jun 01; 36(6):844-50. PubMed ID: 22592144
    [Abstract] [Full Text] [Related]

  • 11. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
    Fugazzola L, Puxeddu E, Avenia N, Romei C, Cirello V, Cavaliere A, Faviana P, Mannavola D, Moretti S, Rossi S, Sculli M, Bottici V, Beck-Peccoz P, Pacini F, Pinchera A, Santeusanio F, Elisei R.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):455-64. PubMed ID: 16728573
    [Abstract] [Full Text] [Related]

  • 12. Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma.
    Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW.
    Horm Metab Res; 2009 Jun 01; 41(6):482-7. PubMed ID: 19370505
    [Abstract] [Full Text] [Related]

  • 13. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas.
    Takano T, Ito Y, Hirokawa M, Yoshida H, Miyauchi A.
    Br J Cancer; 2007 May 21; 96(10):1549-53. PubMed ID: 17453004
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BRAF(V600E) mutation and the biology of papillary thyroid cancer.
    Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R.
    Endocr Relat Cancer; 2008 Mar 21; 15(1):191-205. PubMed ID: 18310287
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA.
    Cancer Res; 2003 Aug 01; 63(15):4561-7. PubMed ID: 12907632
    [Abstract] [Full Text] [Related]

  • 18. BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy.
    Santoro A, Pannone G, Carosi MA, Francesconi A, Pescarmona E, Russo GM, Feola A, Losito S, Franco R, Nappi L, Aquino G, De Rosa G, Di Domenico M, Bufo P.
    J Cell Biochem; 2013 May 01; 114(5):1174-82. PubMed ID: 23192464
    [Abstract] [Full Text] [Related]

  • 19. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.
    Sheu SY, Vogel E, Worm K, Grabellus F, Schwertheim S, Schmid KW.
    Histopathology; 2010 Apr 01; 56(5):632-40. PubMed ID: 20459574
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
    Erickson LA, Jin L, Nakamura N, Bridges AG, Markovic SN, Lloyd RV.
    Cancer; 2007 May 15; 109(10):1965-71. PubMed ID: 17387744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.